NAMCP 2012

Coverage

   |    NAMCP 2012
Check out photos from this year's Fall Managed Care Forum which took place from November 8-9. The meeting was held at the Bellagio Hotel and Convention Center in Las Vegas, Nevada.
   |    NAMCP 2012
In this video, Robin Gelburd, President, FAIR Health, says that cost transparency has been well received by consumers. Consumers are being asked to take on more control of the costs with their health plans. It is important for them to understand what the out-of-pocket costs will be.
   |    NAMCP 2012
Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that treatment-related factors used to stratify patients to prevent chemotherapy-induced nausea and vomiting are the actual chemotherapy drugs.
   |    NAMCP 2012
Thomas Stinchcombe, MD, assistant professor of clinical research, UNC Lineberg Comprehensive Cancer Center, discusses the treatment of patients with non-small cell lung cancer (NSCLC).
   |    NAMCP 2012
Robin Gelburd, President of FairHealth, gave the keynote presentation on Friday at the NAMCP Fall Managed Care Forum. Her presentation, Cost Transparency: How Educated Consumers Are Driving Change, covered a number of reasons that illustrate why data transparency can lead to a chain reaction involving better consumer decisions and lowered costs.
   |    NAMCP 2012
Gary Owens, MD, Gary Owens Associates, says that trends in rheumatoid arthritis management are coming from the new 2012 American College of Rheumatology guidelines that call for earlier and more aggressive treatment of new patients as well as patients who are not doing well on existing therapies.
   |    NAMCP 2012
New revenue models in healthcare are causing innovative payer-provider partnerships. John Harris, MBA, spoke about some of these new partnerships and how all stakeholders must consider each other's mindsets when choosing a model that works for them.
   |    NAMCP 2012
Richard Stefanacci, DO, Associate Professor, Health Policy & Public Health, University of the Sciences, says there are 2 cost concerns associated with neurodegenerative diseases.
Feature
$vacMongoViewPlus$